Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
3.62 USD | +2.09% | +17.15% | -49.44% |
May. 15 | Sector Update: Health Care Stocks Advance in Afternoon Trading | MT |
May. 15 | CASI Pharmaceuticals Gets FDA Clearance For Blood Disorder Study | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-49.44% | 46.06M | |
+37.47% | 727B | |
-7.84% | 354B | |
+15.65% | 328B | |
-0.44% | 277B | |
+13.47% | 243B | |
+7.35% | 205B | |
-6.42% | 203B | |
+3.92% | 164B | |
-1.96% | 164B |
- Stock Market
- Equities
- CASI Stock
- News CASI Pharmaceuticals, Inc.
- Oppenheimer Adjusts CASI Pharmaceuticals' Price Target to $35 From $6 After Reverse Stock Split, Maintains Outperform Rating